ABOUT AbClon
Overview
History
Business Portfolio
Scientific Advisory
Contact Us
ÀÎÀç»ó
º¹¸®ÈÄ»ý/ä¿ëÀýÂ÷
ÀÔ»çÁö¿ø
TECHNOLOGY
Biosynergy Antibody
YPLUS
AffiMab
THERAPEUTIC ANTIBODY
Pipeline
Antibody Drug Industry
ANTIBODY SERVICE
INVESTORS
ÁÖ°¡Á¤º¸
°ø½ÃÁ¤º¸
½ÃÀ庸°í¼
NOTICE
Notice/News
¤ýHome > Community > Notice / News
Total:
111
, page:
2/8
96
¾ÛŬ·Ð, Äڷγª19 Ç×ü½Å¾à Èĺ¸ µµÃâ ¼º°ø
°ü¸®ÀÚ
2020-04-23
687
95
¾ÛŬ·Ð, °íÇü¾Ï CAR-T Ä¡·áÁ¦(AT501) ÀÓ»ó ¹°Áú µµÃâ ¼º°ø
°ü¸®ÀÚ
2020-04-21
357
94
¾ÛŬ·Ð, CAR-T ÀÓ»ó ¼öÇà ¾÷¹« À§Å¹ °è¾à ü°á
°ü¸®ÀÚ
2020-04-17
333
93
¾ÛŬ·Ð, Äڷγª19 ÀÌÁßÇ×ü ¹× ¾îÇǹٵð ´Üµ¶Ä¡·áÁ¦ °³¹ß Âø¼ö
°ü¸®ÀÚ
2020-04-13
922
92
¾ÛŬ·Ð, Äڷγª19 Ç×üġ·áÁ¦ °³¹ß ½º¿þµ§ HPA¿Í °øµ¿ ´ëÀÀ
°ü¸®ÀÚ
2020-04-07
654
91
¾ÛŬ·Ð, Äڷγª19 °áÇÕ ½Å±Ô Àΰ£Ç×ü ´Ù¼ö µµÃâ ¼º°ú
°ü¸®ÀÚ
2020-03-30
847
90
Á¦ 10 ±â °á»ê°ø°í
°ü¸®ÀÚ
2020-03-24
327
89
¾ÛŬ·Ð, »çÀÌÅäÄ«ÀÎ Á¶Àý Ç×ü½Å¾à AM201 ¹Ì±¹ ƯÇã Ãëµæ
°ü¸®ÀÚ
2020-03-19
637
88
¾ÛŬ·Ð, Äڷγª19 Ç×ü °³¹ß Ãѷ¡¦ÃÖ¿ì¼± °úÁ¦·Î ¼ÓµµÀü
°ü¸®ÀÚ
2020-03-17
576
87
¾ÛŬ·Ð, Çѱ¹ÈÇבּ¸¿ø°ú Äڷγª19 ½Å¼ÓÁø´ÜÁ¦ °³¹ß ±¹Ã¥ °úÁ¦ ¼±Á¤
°ü¸®ÀÚ
2020-03-05
1,294
86
¾ÛŬ·Ð, CAR-T ÀÓ»ó¿ë ¹ÙÀÌ·²º¤ÅÍ »ý»ê °è¾à
°ü¸®ÀÚ
2020-02-19
734
85
¾ÛŬ·Ð, Ç×ü±â¼úÀÌÀüÀ¸·Î 2019»ç¾÷¿¬µµ ÈæÀÚÀüȯ
°ü¸®ÀÚ
2020-02-11
380
84
¾ÛŬ·Ð, Çѱ¹ÈÇבּ¸¿ø°ú ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º Ç×ü °øµ¿°³¹ß Çù¾à
°ü¸®ÀÚ
2020-02-11
657
83
¾ÛŬ·Ð, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º Ç×ü °³¹ßŰ·Î
°ü¸®ÀÚ
2020-01-31
519
82
¾ÛŬ·Ð, Ææ½Çº£´Ï¾Æ Àǰú´ëÇаú Çõ½Å CAR-T °øµ¿ °³¹ß
°ü¸®ÀÚ
2020-01-31
94
1
2
3
4
5
6
7
8
Á¦¸ñ
³»¿ë
±Û¾´ÀÌ